Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

BACKGROUND: The effectiveness of biologic therapies, primarily tumor necrosis factor inhibitors (TNFi), for children with spondyloarthritis (SpA) has made inactive disease a realistic patient outcome. However, biologic therapies are costly, primarily delivered by subcutaneous or intravenous route, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Pamela F., Sears, Cora E., Brandon, Timothy G., Forrest, Christopher B., Neu, Emily, Kohlheim, Melanie, Leal, Jenny, Xiao, Rui, Lovell, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906941/
https://www.ncbi.nlm.nih.gov/pubmed/36755328
http://dx.doi.org/10.1186/s13063-022-07038-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906941/
https://www.ncbi.nlm.nih.gov/pubmed/36755328
http://dx.doi.org/10.1186/s13063-022-07038-6

Ejemplares similares